First Choice Healthcare Solutions, INC. (FCHS) — SEC Filings

Overview

First Choice Healthcare Solutions, INC. (FCHS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a S-1/A filed on Dec 30, 2025: First Choice Healthcare Solutions, Inc. (FCHS) is undertaking a firm commitment public offering of 2,400,000 shares of Series D Convertible Preferred Stock and accompanying Warrants to purchase an equal number of Series D Preferred Stock, aiming to raise $12,000,000 at a public offering price of $5.

Sentiment Summary

Across 17 filings, the sentiment breakdown is: 5 bearish, 11 neutral, 1 mixed. The dominant filing sentiment for First Choice Healthcare Solutions, INC. is neutral.

Filing Type Overview

First Choice Healthcare Solutions, INC. (FCHS) has filed 7 S-1/A, 6 10-Q, 2 8-K, 1 10-K, 1 S-1 with the SEC between May 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (17)

• FCHS Launches $12M Offering, Reverse Split, CEO Cedes Super-Voting Control — S-1/A · Dec 30, 2025 Risk: high
  First Choice Healthcare Solutions, Inc. (FCHS) is undertaking a firm commitment public offering of 2,400,000 shares of Series D Convertible Preferred Stock and
• FCHS Aims for $12M IPO, Reverse Split, CEO Cedes Super-Voting Control — S-1/A · Dec 8, 2025 Risk: high
  First Choice Healthcare Solutions, Inc. (FCHS) is filing an S-1/A to register 2,400,000 shares of Series D Convertible Preferred Stock and accompanying Warrants
• FCHS Net Loss Widens 79% Amid Soaring Expenses, Cash Dwindles — 10-Q · Nov 12, 2025 Risk: high
  First Choice Healthcare Solutions, Inc. (FCHS) reported a significant increase in net loss for the three months ended September 30, 2025, reaching $1,462,888, u
• FCHS Launches $12M IPO of Convertible Preferred Stock, Warrants — S-1/A · Sep 24, 2025 Risk: high
  First Choice Healthcare Solutions, Inc. (FCHS) is conducting an initial public offering of 2,400,000 shares of Series D Convertible Preferred Stock and accompan
• FCHS Revenue Halves, Net Loss Persists Amidst Mounting Debt — 10-Q · Aug 13, 2025 Risk: high
  First Choice Healthcare Solutions, Inc. (FCHS) reported a significant net loss of $2,037,329 for the six months ended June 30, 2025, a 34.4% improvement from th
• FCHS Amends S-1/A, Updates Capital Structure & Convertible Debt — S-1/A · Jul 2, 2025 Risk: high
  First Choice Healthcare Solutions, Inc. (FCHS) filed an S-1/A on July 2, 2025, indicating a registration statement amendment. The filing provides updated financ
• First Choice Healthcare Solutions Announces Leadership Changes — 8-K · Jun 27, 2025 Risk: medium
  On June 10, 2025, First Choice Healthcare Solutions, Inc. reported the departure of director David A. Smith and the appointment of new director Michael J. Burli
• First Choice Healthcare Solutions Files Q1 2025 10-Q — 10-Q · May 15, 2025 Risk: low
  First Choice Healthcare Solutions, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Medical Billing Assistan
• First Choice Healthcare Solutions Files 2024 10-K — 10-K · Apr 15, 2025 Risk: low
  First Choice Healthcare Solutions, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on April 15, 2025. The company, formerly known as Medical B
• First Choice Healthcare Solutions: Board & Compensation Changes — 8-K · Mar 31, 2025 Risk: medium
  On February 25, 2025, First Choice Healthcare Solutions, Inc. reported a change in its board of directors and executive compensation arrangements. The filing de
• First Choice Healthcare Solutions Files S-1/A Amendment — S-1/A · Mar 11, 2025 Risk: medium
  First Choice Healthcare Solutions, Inc. filed an S-1/A amendment on March 11, 2025, detailing its financial structure. The company, formerly Medical Billing Ass
• First Choice Healthcare Solutions Files S-1/A Amendment — S-1/A · Dec 30, 2024 Risk: medium
  First Choice Healthcare Solutions, Inc. filed an S-1/A amendment on December 30, 2024, related to its registration statement. The company, formerly known as Med
• First Choice Healthcare Solutions Files Q3 2024 Report — 10-Q · Nov 13, 2024 Risk: low
  First Choice Healthcare Solutions, Inc. filed its quarterly report for the period ending September 30, 2024. The company, formerly known as Medical Billing Assi
• First Choice Healthcare Solutions Files S-1/A Amendment — S-1/A · Sep 9, 2024 Risk: medium
  First Choice Healthcare Solutions, Inc. filed an S-1/A amendment on September 9, 2024, detailing its financial status. The company, formerly known as Medical Bi
• First Choice Healthcare Solutions Files Q2 2024 10-Q — 10-Q · Aug 14, 2024 Risk: low
  First Choice Healthcare Solutions, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Medical Billing Assistance, Inc., is
• First Choice Healthcare Solutions Q1 2024 10-Q Filed — 10-Q · May 31, 2024 Risk: medium
  First Choice Healthcare Solutions, Inc. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and operational updates fo
• First Choice Healthcare Solutions Files S-1 for Potential Public Offering — S-1 · May 13, 2024 Risk:
  First Choice Healthcare Solutions, Inc. (FCHS) filed a IPO Registration (S-1) with the SEC on May 13, 2024. First Choice Healthcare Solutions, Inc. filed an S-1

Risk Profile

Risk Assessment: Of FCHS's 16 recent filings, 6 were flagged as high-risk, 6 as medium-risk, and 4 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from First Choice Healthcare Solutions, INC.'s most recent 10-Q filing (Nov 12, 2025):

• Revenue: $230
• Net Income: -$1,462,888
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: $2,430
• Operating Margin: N/A
• Total Assets: N/A
• Total Debt: $25,658,086

Key Executives

• Lance Friedman
• Arthur S. Marcus, Esq.
• Thomas J. Poletti, Esq.
• David A. Smith
• Michael J. Burlison

Industry Context

First Choice Healthcare Solutions is pivoting into the primary care and wellness clinic sector, focusing on life improvement services like anti-aging, weight management, and hormone replacement, alongside pharmacy services. This market is characterized by increasing demand for preventative and personalized healthcare solutions, driven by an aging population and growing consumer interest in wellness. The competitive landscape includes established healthcare providers, specialized clinics, and emerging direct-to-consumer health tech companies.

Top Tags

10-Q (5) · healthcare (5) · financials (4) · Warrants (3) · Reverse Stock Split (3) · Dilution Risk (3) · IPO (3) · S-1/A (2) · Corporate Governance (2) · Capital Raise (2)

Key Numbers

• Total Public Offering Price: $12,000,000 — Gross proceeds from the offering of 2,400,000 shares of Series D Preferred Stock and Warrants at $5.00 each.
• Underwriting Discounts and Commissions: $960,000 — 8% of the total public offering price.
• Proceeds to FCHS (before expenses): $11,040,000 — Net proceeds after underwriting discounts.
• Shares of Series D Convertible Preferred Stock: 2,400,000 — Number of shares offered in the IPO.
• Warrants to Purchase Series D Preferred Stock: 2,400,000 — Number of warrants offered alongside preferred stock.
• Assumed Initial Conversion/Exercise Price: $5.00 — Per share price for Series D Preferred Stock and Warrants.
• Total Common Stock Registered: 8,124,000 — Estimated shares issuable upon conversion of all Series D Preferred Stock and payment of dividends.
• Proposed Reverse Stock Split Ratio: 1 for 2,000 — Applicable to 32,958,288 outstanding common shares.
• Shares for Resale by Selling Stockholders: 720,000 — Includes 51,114 shares from warrant exercises.
• Series A Super Voting Preferred Stock Shares: 4 — Held by CEO Lance Friedman, to be cancelled upon offering completion.
• Public Offering Price per Share/Warrant: $5.00 — Combined price for one share of Offered Preferred Stock and one Warrant
• Proceeds to Company (before expenses): $11,040,000 — Net proceeds after $960,000 in underwriting discounts
• Warrants to Purchase Series D Convertible Preferred Stock: 2,400,000 — Number of warrants offered in the IPO
• Reverse Stock Split Ratio: 1 for 2,000 — Approved reverse split for common stock outstanding as of December 8, 2025
• Warrant Expiration Anniversary: 5 — Warrants will expire on the fifth anniversary of the initial issuance date

Frequently Asked Questions